Medicine & Health

Joy Jiang, assistant professor of surgery in the Division of Public Health Sciences at the School of Medicine, received a four-year $1.35 million MERIT award from the National Institutes of Health (NIH) for her project “Dynamic prediction incorporating time-varying covariates for the onset of breast cancer.”

There is a strong association between high levels of physical activity and the ability to maintain cognitive function among breast cancer patients treated with chemotherapy, according to new research from Washington University School of Medicine.

Joe Rowles, a postdoctoral research associate working with Gary Patti in chemistry in Arts & Sciences, won a Molecular Oncology Training Grant to support his participation in the Siteman Cancer Center’s Cancer Biology Pathway Program.

Adolescents and young adults living in rural versus metropolitan U.S. counties and those living farther from the hospital where they were diagnosed generally have worse outcomes than those living in metropolitan counties and closer to the reporting hospital, finds a new study from the Brown School.

Julie O’Neal, assistant professor of medicine at the School of Medicine, received a $250,000 award from the International Myeloma Society. The award will be used to develop novel immunotherapy treatments for multiple myeloma, a common blood cancer.

Researchers at Washington University School of Medicine have shown in preclinical studies that a natural killer cell-based immunotherapy could be effective against solid tumors such as melanoma.

Carmen R. Bergom, MD, PhD, associate professor of radiation oncology at the School of Medicine, will receive the 2021 Michael Fry Research Award from the Radiation Research Society. The annual award recognizes a junior scientist who has made extraordinary contributions to the field of radiation research.

Jeffrey P. Henderson, MD, PhD, at Washington University School of Medicine, is an author on a new study that shows that convalescent plasma from recovered COVID-19 patients can dramatically increase the likelihood of survival for blood cancer patients hospitalized with COVID-19.

A new study led by Washington University School of Medicine provides new guidance on the treatment of medulloblastoma, a pediatric brain cancer. Some aspects of radiation therapy may be reduced while still providing effective treatment.

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The study is led by scientists at the School of Medicine and other institutions.